Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex
暂无分享,去创建一个
J. Egmond | L. Booij | F. Donati | J. Driessen | H. D. Boer
[1] M. Jacka,et al. Steroids in fibroproliferative acute respiratory distress syndrome: approach with care , 2007, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[2] F. Donati. Sugammadex: an opportunity for more thinking or more cookbook medicine? , 2007, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[3] M. Revel,et al. Comparison of two fluid-management strategies in acute lung injury, H.P. Wiedemann, A.P. Wheeler, G.R. Bernard, B.T. Thompson, D. Hayden, B. deBoisblanc, A.F Jr. Connors, R.D. Hite, A.L. Harabin, in: N Engl J Med, 354. (2006), 2564 , 2007 .
[4] J. van Egmond,et al. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation. , 2006, British journal of anaesthesia.
[5] J. van Egmond,et al. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. , 2006, British journal of anaesthesia.
[6] G. Bernard,et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. , 2006, The New England journal of medicine.
[7] R. Hyzy,et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. , 2006, The New England journal of medicine.
[8] S. Ramael,et al. First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide , 2005, Anesthesiology.